Cimas takes lead in fight against cardiovascular diseases
CIMAS Health Group has taken the lead in the fight against cardiovascular diseases which are fast becoming leading causes of death.
By Vanessa Gonye
Sep. 29, 2025
B7-33 Peptide: A potential catalyst in fibrosis and cardiovascular research
B7-33 is engineered to retain the core functionalities of H2-relaxin while simplifying its structure to a single-chain format.
By Amh Voices
Apr. 2, 2025




